CLINICAL_TRIALS
trial_result
· 2024-05-01
Clinical Trial Update: A Randomized Controlled Trial of Doxazosin for Nightmares, Sleep Disturbance, and Non-Nightmare Clinical Symptoms in PTSD [Phase 2]
Summary
Phase 2 randomized trial evaluating doxazosin for nightmares, sleep disturbance, and non-nightmare PTSD symptoms; sponsored by the San Francisco VA Medical Cent…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: San Francisco Veterans Affairs Medical Center | Conditions: Stress Disorders, Post-Traumatic | Phase 2 | Status: ACTIVE_NOT_RECRUITING